Please assess the completion status of the following clinical trial:

Trial Title: Study to Examine the Effect on Glucose Control and Safety/Tolerability of Exenatide Given Two Times a Day to Subjects With Type 2 Diabetes

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE3
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* The subject has an HbA1c value \<=11.0%~* The subject has a body mass index (BMI) of 25 kg/m\^2 to 45 kg/m\^2, inclusive~Exclusion Criteria:~* Is currently treated with certain medications, including exogenous insulin

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 70 Years
- Healthy Volunteers: f

Study Arms:
- Exenatide (Type: EXPERIMENTAL): Exenatide 5 mcg for 4 weeks (transition) then 10 mcg to study termination

Based on this trial design, predict the completion outcome and termination type (if applicable).